Dr. Reddy's Laboratories Limited (RDY)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Show:
Annual
Income statement
Currency in INR. All numbers in thousandsBreakdown
ttm
31/03/2023
31/03/2022
31/03/2021
Total revenue
271,302,000
245,879,000
214,391,000
189,722,000
Cost of revenue
113,181,000
106,536,000
100,551,000
86,645,000
Gross profit
158,121,000
139,343,000
113,840,000
103,077,000
Operating expenses
Research development
21,362,000
19,381,000
17,482,000
16,541,000
Selling general and administrative
74,717,000
68,026,000
62,081,000
54,650,000
Total operating expenses
93,032,000
80,289,000
77,921,000
70,167,000
Operating income or loss
65,089,000
59,054,000
35,919,000
32,910,000
Interest expense
1,472,000
1,428,000
958,000
970,000
Total other income/expenses net
3,387,000
1,561,000
-3,628,000
-6,353,000
Income before tax
69,109,000
60,367,000
32,298,000
26,413,000
Income tax expense
16,903,000
15,300,000
8,730,000
9,175,000
Income from continuing operations
52,206,000
45,067,000
23,568,000
17,238,000
Net income
52,206,000
45,067,000
23,568,000
17,238,000
Net income available to common shareholders
52,206,000
45,067,000
23,568,000
17,238,000
Basic EPS
306.20
271.43
142.08
103.94
Diluted EPS
305.55
270.85
141.69
103.65
Basic average shares
166,178
166,035
165,883
165,844
Diluted average shares
166,530
166,388
166,339
166,316
© 2024 Yahoo. All rights reserved.